Nerve Pain and Foot Ulcers Researches
The immune system has the ability to defeat cancer, but often needs to be turned up to work effectively. One immune protein that can work well is called IL-18, but is not very active in most types of cancer. Professor Master’s team has designed a product that increases IL-18 activity and is looking to turn this into an anti-cancer therapy.
Lead researcher | Professor Seth Masters
New treatment Discovered by Prof Hertzog’s team, interferon epsilon is found in the reproductive tract of women where it activates the local innate immune response that controls inflammation. This process is important in protect us from infections and also the development and spread of cancer. The team is developing a novel candidate for the treatment of ovarian cancer with a commercial partner.
Lead Researcher | Professor Paul Hertzog
Molecular studies. Cancer cells are good at hiding from the immune system. However, if immune cells engage with tumours, the immune system can learn to recognise and remove every single cancer cell. Associate Professor Gantier is investigating how RNA therapeutics, similar to those used in mRNA vaccines, can be used to reignite immune activity in tumour cells to drive systemic anti-tumoral responses. This work has immense potential for the treatment many different cancers, including leukaemia.
Lead Researcher | Associate Professor Michael Gantier